Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Announcement Wellgistics, a known face in the integration of technology and physical healthcare infrastructure for the major prescription drugs, have introduced EinsteinRx™. The EinsteinRx&tra...
Announcement Niagen Bioscience, Inc., the leading global authority on NAD+ (nicotinamide adenine dinucleotide) with an aim on the science of healthy ageing, have shared dedicated results from the be...
Announcement Neurogene Inc., a clinical-level leading company built to introduce life-changing, transformative genetic medicines to families and patient groups suffering from rare neurological disea...
Announcement With the end of the year, the flashback to the transformative trends has been a memorable positive change in the healthcare sector that brought new hope and modernisation upgrade to the...
Announcement Centessa Pharmaceuticals plc, a leading clinical-level pharmaceutical company, has fixed the pricing value of its underwritten public offering of around 11,627,907 American Depositary S...
Announcement Dare Bioscience, Inc. is an intention-driven, accelerated biotech company completely targeting covering the gap between real-world solutions and promising science to improve women’...
Announcement Galvanize Therapeutics Inc., a leading marketing pro medical technology company featuring pulsed electric field (PEF) therapies for chronic lung disease and oncology, opted for the onlin...
Announcement Repair Biotechnologies Inc. highlighted its current presentation of preclinical data proving the regression and potential of atherosclerotic plaque with REP-0003 treatment under its pre...
Announcement AN2 Therapeutics, Inc., a leading biopharmaceutical company specialising in small molecule therapeutics with its comprehensive boron chemistry platform, has fixed a research collaborati...
Announcement Idorsia Ltd. has published the new evaluation, a slight improvement from the landmark Phase 3 PRECISION study, in the Journal of Hypertension with the title ‘Effects of aprocitent...
Speak with a healthcare analyst about your research, consulting, or platform needs.